Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystal Light and Potassium Citrate for Urinary Stone Risk Factors
NCT05389995Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Aug 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of potassium citrate in nephrolithiasis (3 arms), sponsored by Northwestern University. Primary endpoint: Urine citrate levels. Started Aug 2022; status: active, not recruiting.
02
Drugs
potassium citrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT05389995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05389995.